Activation of extracellular transglutaminase 2 by thioredoxin
about
Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrixTransglutaminase 2-mediated serotonylation in pulmonary hypertensionCellular functions of tissue transglutaminaseRole of transglutaminase 2 in celiac disease pathogenesisAstrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelinationTransglutaminase regulation of cell function.Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.A universal entropy-driven mechanism for thioredoxin-target recognition.P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis?Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer ProgressionP2X7 receptor activation regulates rapid unconventional export of transglutaminase-2.Regulation of the activities of the mammalian transglutaminase family of enzymes.Thiol-Disulfide Exchange Reactions in the Mammalian Extracellular Environment.Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxinSecreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.Transglutaminase as a therapeutic target for celiac disease.Coeliac disease - from genetic and immunological studies to clinical applications.Polyamines: therapeutic perspectives in oxidative stress and inflammatory diseases.Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes.Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.Interplay between transglutaminases and heparan sulphate in progressive renal scarring.Structural aspects of transglutaminase 2: functional, structural, and regulatory diversity.An unprecedented dual antagonist and agonist of human Transglutaminase 2.Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice.Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation.Selective inhibition of extracellular thioredoxin by asymmetric disulfides.Endothelial cell-surface tissue transglutaminase inhibits neutrophil adhesion by binding and releasing nitric oxide.Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.Polyamines and transglutaminases: future perspectives.An isomerase completes the circuit for a redox switch.Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2.Cystamine and cysteamine as inhibitors of transglutaminase activity
P2860
Q24309155-71479DA5-8733-405F-A487-9232371E16EEQ27027862-53EE71B2-DFFB-482C-AEC1-DF77D20D4FD7Q28260600-EDC3529B-8C35-44C2-B6F4-64B45C9DAFA0Q28262529-3539AF28-26F8-4D95-866B-024CB287F9E2Q29248440-FD2B9545-1391-4120-A988-BF237CFF36D0Q33707936-38D3B164-E8B4-45A0-88A6-EF078BE7B6F8Q34661302-D181801D-175A-4860-8BBB-CAEC45BC68A8Q35018831-A42B9BE8-8CA1-448D-B3DE-B6388180BA52Q35818808-815411BD-83C0-4511-827B-23EE0867CAEEQ36113827-C03E8220-A3FA-4465-BE23-799F073A4F3FQ36117713-3619B32E-57DA-42AC-B795-E00CC9C82C47Q36417661-89F77F8B-A05D-437F-A162-9D544CDFCDD9Q36620140-1E16F923-9AE1-49F4-B3BE-357B893A926AQ36984552-8B2FB9AD-E852-4054-AD48-A68FEC721F57Q37250664-F12D8220-DFEF-4F35-A632-8300AFC444FAQ37651981-9D46CEC6-8272-431F-9E4D-63C5F8B297ECQ38269678-75AF419B-F00D-40D2-910F-0C75CE74CCA6Q38408084-3F00AFEE-DB93-4B39-9E5C-CCA0DE9DDA51Q38653424-58396D0A-AC01-437B-9612-AD2AB5F45AA3Q38724906-60F890F9-7496-44CF-B9A3-34D89E48C8BFQ38736418-85C3AB4A-B00A-4661-9653-BF887C7DE06FQ38855195-39B2AF9E-7C33-49B8-B00A-061D0CB53823Q38857583-C1089AD2-85BB-4966-B32D-CB3FE4C98C1FQ39017211-EF59A871-2CEF-4C68-8312-C6ADC5BC6C07Q39330237-95A9F32B-81F7-4DCD-8068-BD65FBDDA5E4Q39414447-3E77CE7C-4960-48A1-BAC1-32E9320C62DFQ41810803-0AAE01F2-61BD-4751-9F79-E93508C80379Q41968228-73D9F537-B6B0-4A98-9E91-85C1E94F41D0Q42547773-B0B2F8F1-233F-4576-B317-BBFA773AD4DCQ43246200-AB9579C6-F3B7-4CF3-9503-F5B412B66B29Q47100916-8474D2DE-8E5E-4330-817A-29B9097CCE94Q47228617-942C42E6-AD8C-40CB-AE60-AE6AA06AFA26Q50891054-FF2621F4-2211-427C-A6B2-61065F20D609Q52687745-16F01C64-CDD4-4FD3-B123-3F6E9258A59EQ53764493-848F171C-CADC-4248-ACE4-346164180D74Q58763905-30FE882A-3CC8-45C5-AC9B-208B7C29C9E9
P2860
Activation of extracellular transglutaminase 2 by thioredoxin
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of extracellular transglutaminase 2 by thioredoxin
@ast
Activation of extracellular transglutaminase 2 by thioredoxin
@en
Activation of extracellular transglutaminase 2 by thioredoxin
@nl
type
label
Activation of extracellular transglutaminase 2 by thioredoxin
@ast
Activation of extracellular transglutaminase 2 by thioredoxin
@en
Activation of extracellular transglutaminase 2 by thioredoxin
@nl
prefLabel
Activation of extracellular transglutaminase 2 by thioredoxin
@ast
Activation of extracellular transglutaminase 2 by thioredoxin
@en
Activation of extracellular transglutaminase 2 by thioredoxin
@nl
P2093
P2860
P3181
P356
P1476
Activation of extracellular transglutaminase 2 by thioredoxin
@en
P2093
Chaitan Khosla
Cornelius Klöck
Jorunn Stamnaes
Ludvig M Sollid
Thomas R DiRaimondo
P2860
P304
P3181
P356
10.1074/JBC.M111.287490
P407
P577
2011-10-28T00:00:00Z